Pharmacokinetics of Nafamostat, a Potent Serine Protease Inhibitor, by a Novel LC-MS/MS Analysis

Nafamostat, a synthetic serine protease inhibitor, has been used for the treatment of inflammatory diseases such as pancreatitis. Recently, an increasing number of studies have shown the promising antiviral effects of nafamostat for the treatment of coronavirus disease-19 (COVID-19). This study aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Hyeon Seok, Kim, Taehyung, Gu, Dong-Hyeon, Lee, Tae Suk, Kim, Tae Hwan, Shin, Soyoung, Shin, Beom Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955020/
https://www.ncbi.nlm.nih.gov/pubmed/35335247
http://dx.doi.org/10.3390/molecules27061881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955020/
https://www.ncbi.nlm.nih.gov/pubmed/35335247
http://dx.doi.org/10.3390/molecules27061881

Ejemplares similares